Sciensus Rare News Today

Investegate announcements from MGC Pharmaceuticals, December 2022 Quarterly Activities and Cash Flow

Investegate announcements from MGC Pharmaceuticals, Operations Update - Major Milestones Achieved

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has achieved several key milestones recently throughout its EU GMP production facilities and with its...

Biotech companies develop diagnostics and drugs involved in human health, so there will always be lengthy processes to usher assets onto the market,...

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has received the first funding tranche of US$1.2 million under the new US$10 million financing...

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has entered into a US$10 million financing agreement with Mercer Street Global Opportunity Fund LLC, a...

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief executive Roby Zomer said he is confident as the company continues to advance products through...

Investegate announcements from MGC Pharmaceuticals, Chief Commercial Officer Appointment

Investegate announcements from MGC Pharmaceuticals, CogniCann� Phase II Clinical Trial Results

Investegate announcements from MGC Pharmaceuticals, March Quarterly Activities Report and Cash Flow